What is Regenxbio's net investment in lease?

Regenxbio (RGNX) reported net investment in lease of $45.54M in Q1 2026.

How has Regenxbio's net investment in lease changed year-over-year?

Regenxbio's net investment in lease decreased by 12.6% year-over-year, from $52.11M to $45.54M.

What is the long-term trend for Regenxbio's net investment in lease?

Over 5 years (2020 to 2025), Regenxbio's net investment in lease has grown at a -5.9% compound annual growth rate (CAGR), from $63.82M to $47.16M.

Regenxbio RGNX Net Investment in Lease

Net Investment in Lease at other companies

Sarepta Therapeutics, Inc.SRPT

——

BiogenBIIB

——

EyePoint, Inc. EYPT

——

4D Molecular TherapeuticsFDMT

——

Solid Biosciences Inc.SLDB

——

Immix Biopharma, Inc.IMMX

——

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's net investment in lease?: Regenxbio (RGNX) reported net investment in lease of $45.54M in Q1 2026.
How has Regenxbio's net investment in lease changed year-over-year?: Regenxbio's net investment in lease decreased by 12.6% year-over-year, from $52.11M to $45.54M.
What is the long-term trend for Regenxbio's net investment in lease?: Over 5 years (2020 to 2025), Regenxbio's net investment in lease has grown at a -5.9% compound annual growth rate (CAGR), from $63.82M to $47.16M.